Huybrecht T’jollyn

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers

P. Ascierto, R. Plummer, E. Felip, 2022, Cancer Chemotherapy and Pharmacology.

Development and validation of a fast and uniform approach to quantify β-lactam antibiotics in human plasma by solid phase extraction-liquid chromatography-electrospray-tandem mass spectrometry.

K. Boussery, P. Colin, J. Van Bocxlaer, 2013, Talanta.

Efficacy and safety exposure–response relationships of apalutamide in patients with metastatic castration-sensitive prostate cancer: results from the phase 3 TITAN study

N. Agarwal, O. Ackaert, S. Chowdhury, 2022, Cancer Chemotherapy and Pharmacology.

Model-Informed Clinical Development of 6-Monthly Injection of Paliperidone Palmitate in Patients with Schizophrenia: Dosing Strategies Guided by Population Pharmacokinetic Modeling and Simulation (Part II).

J. Pérez-Ruixo, S. Gopal, Alberto Russu, 2024, European journal of drug metabolism and pharmacokinetics.

Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated–Hepatitis B Virus–Infected Mice

N. Goeyvaerts, J. Pérez-Ruixo, A. Vermeulen, 2022, The Journal of Pharmacology and Experimental Therapeutics.

Physiologically Based Pharmacokinetic Predictions of Tramadol Exposure Throughout Pediatric Life: an Analysis of the Different Clearance Contributors with Emphasis on CYP2D6 Maturation

A. Peer, K. Boussery, K. Allegaert, 2015, The AAPS Journal.

Development and validation of a fast and sensitive UPLC-MS/MS method for the quantification of six probe metabolites for the in vitro determination of cytochrome P450 activity.

K. Boussery, P. Colin, J. Van Bocxlaer, 2012, Talanta.